These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 842938)

  • 21. Relationships between the lipid content and the rheological properties of airway secretions in cystic fibrosis.
    Galabert C; Jacquot J; Zahm JM; Puchelle E
    Clin Chim Acta; 1987 Apr; 164(2):139-49. PubMed ID: 3594907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phospholipid composition and surface-active properties of tracheobronchial secretions from patients with cystic fibrosis and chronic obstructive pulmonary diseases.
    Girod S; Galabert C; Lecuire A; Zahm JM; Puchelle E
    Pediatr Pulmonol; 1992 May; 13(1):22-7. PubMed ID: 1589308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel approach for analysis of bronchoalveolar lavage fluid (BALF) using HPLC-QTOF-MS-based lipidomics: lipid levels in asthmatics and corticosteroid-treated asthmatic patients.
    Kang YP; Lee WJ; Hong JY; Lee SB; Park JH; Kim D; Park S; Park CS; Park SW; Kwon SW
    J Proteome Res; 2014 Sep; 13(9):3919-29. PubMed ID: 25040188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.
    Postle AD; Mander A; Reid KB; Wang JY; Wright SM; Moustaki M; Warner JO
    Am J Respir Cell Mol Biol; 1999 Jan; 20(1):90-8. PubMed ID: 9870921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid composition of marmoset saliva.
    Murty VL; Slomiany BL; Zdebska E; Slomiany A; Mandel ID; Levy M
    Comp Biochem Physiol A Comp Physiol; 1984; 79(1):41-4. PubMed ID: 6148183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential isolation and biochemical analysis of pulmonary surfactant from human lung homogenate.
    Wali A; Dhall K; Sanyal SN; Juneja R; Majumdar S
    Biochem Int; 1990; 20(5):869-77. PubMed ID: 2350358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Surfactant lipids of bovine lungs].
    Ledwozyw A; Tusińska E; Tusiński M
    Pol Arch Weter; 1991; 31(3-4):93-104. PubMed ID: 1842618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The chronically reserpinized rat as a possible animal model for cystic fibrosis. IV. The protein composition of pulmonary lavage fluid.
    Thompson FE; Quissell DO; Williams CH; Martinez JR
    Pediatr Res; 1976 Jun; 10(6):632-5. PubMed ID: 946902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid composition and chemotaxonomy of Pseudomonas putrefaciens (Alteromonas putrefaciens).
    Wilkinson SG; Caudwell PF
    J Gen Microbiol; 1980 Jun; 118(2):329-41. PubMed ID: 7441198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of lyophilized total pancreas on plasma lipids and on fat absorption in cystic fibrosis.
    Malmendier CL; Van Den Bergen CJ; Baran D
    Helv Paediatr Acta; 1977 Jul; 32(2):115-28. PubMed ID: 617969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid analyses of isolated surface membranes of Leishmania donovani promastigotes.
    Wassef MK; Fioretti TB; Dwyer DM
    Lipids; 1985 Feb; 20(2):108-15. PubMed ID: 3982233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular species compositions of lung and pancreas phospholipids in the cftr(tm1HGU/tm1HGU) cystic fibrosis mouse.
    Dombrowsky H; Clark GT; Rau GA; Bernhard W; Postle AD
    Pediatr Res; 2003 Mar; 53(3):447-54. PubMed ID: 12595593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid content of swine influenza and other vaccines.
    Leskawa KC; Hogan EL; Dasgupta S; Chien JL; Erwin RE; Brostoff SW
    Lipids; 1986 May; 21(5):342-6. PubMed ID: 3724370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The reaction of phosphoglycolipids and other lipids with hydrofluoric acid.
    Shaw N; Stead A
    Biochem J; 1974 Nov; 143(2):461-4. PubMed ID: 4462562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The chronically reserpinized rat as an animal model for cystic fibrosis: I. Acute effect of isoproterenol and pilocarpine upon pulmonary lavage fluid.
    Mawhinney TP; Feather MS; Martinez JR; Barbero GJ
    Pediatr Res; 1979 Jun; 13(6):760-3. PubMed ID: 481944
    [No Abstract]   [Full Text] [Related]  

  • 36. Composition and surface properties of the bronchial lipids in adult patients with cystic fibrosis.
    Gilljam H; Andersson O; Ellin A; Robertson B; Strandvik B
    Clin Chim Acta; 1988 Aug; 176(1):29-37. PubMed ID: 3168291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemistry of very-long-chain and long-chain ceramides in cystic fibrosis and other diseases: The importance of side chain.
    Garić D; De Sanctis JB; Shah J; Dumut DC; Radzioch D
    Prog Lipid Res; 2019 Apr; 74():130-144. PubMed ID: 30876862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of phospholipids in human lung carcinoma.
    Nakamura M; Onodera T; Akino T
    Lipids; 1980 Sep; 15(9):616-23. PubMed ID: 7421416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on pulmonary secretions. 3. The nucleic acids in whole pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy.
    Potter JL; Spector S; Matthews LW; Lemm J
    Am Rev Respir Dis; 1969 Jun; 99(6):909-16. PubMed ID: 5787605
    [No Abstract]   [Full Text] [Related]  

  • 40. Phospholipid composition of gliding bacteria: oral isolates of Capnocytophaga compared with Sporocytophaga.
    Holt SC; Doundowlakis J; Takacs BJ
    Infect Immun; 1979 Oct; 26(1):305-10. PubMed ID: 500209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.